Market Quick Take - April 30, 2020 Market Quick Take - April 30, 2020 Market Quick Take - April 30, 2020

Market Quick Take - April 30, 2020

Macro 3 minutes to read
Steen Jakobsen

Chief Economist & CIO

Summary:  Equities posted a strong session in the US yesterday with some support from hopes for a Gilead drug for treating Covid19 and an FOMC statement pointing to concerns for the medium term, suggesting they will maintain an easier stance for longer. Equities then ripped even higher after the close in the wake of much stronger than expected results from Facebook, in particular.

What is our trading focus?

  • US500.I (S&P 500 Index) and USNAS100.I (Nasdaq 100 Index) – These major US stock indices have torn through local resistance and the Nasdaq is only some 7% from all-time highs, with no resistance lines of note ahead of those highs, while the S&P 500 faces the last major resistance levels ahead of the top in the form of the 200-day moving average and the last major Fibonacci retracement lines a bit higher still. Better than expected earnings with the market especially taking note of earnings from Facebook, Microsoft and Tesla. Major US earnings reports continue today with Apple and Amazon on tap (see below).
  • FB:xnys (Facebook) Facebook shares traded up 10.5% in after-market trading as Q1 numbers were in line with estimates and comments during the conference call that advertiser activity had stabilised in April from the significant drop in March.
  • MSFT:xnas (Microsoft) the greatest monopoly of all-time delivered again with strong results across all business segments. The company said that only smaller companies have put off one-off purchases and else no impact from COVID-19 is visible at this point.
  • Tesla (TSLA:xnas) Tesla delivered Q1 revenue numbers that were better than expected and reported a positive EPS of $1.24 compared to a loss of $2.90 a year ago. The company talked very little about the impact from COVID-19 instead boasting about its investments and aim to have industry leading operating margins. Tesla also said that it expects the Model Y to be the best-selling car ever for the company. On the negative side the free cash flow went back into negative losing $895mn in the quarter compared to a gain of $1.01bn in Q4.
  • Gilead Sciences (GILD:xnas): the biotechnology company announces that its drug Remdesivir has met its primary endpoint in trial for treating COVID-19 saying it leads to 31% faster recovery time compared to the control group. FDA may make an emergency authorization by Wednesday next week, and Gilead’s CEO said that the company had 50,000 courses ready to ship to patients.
  • EURJPY – again, while yesterday’s market backdrop could not have been less supportive for a traditional “safe haven” currency like the JPY, the EURJPY pair again settled lower and remained below the long term support area broken around 116.00-25. That level remains key going into today’s ECB meeting if that meeting fails to produce an indication that the ECB will move more directly to address different funding costs across the EMU.
  • AUDUSD – the AUDUSD rally continued yesterday and is a proxy for risk appetite in the G10 currencies, with the next major resistance point up at the major lows established back in late 2019 around 0.6675. Hopes for a global recovery and recent Chinese stimulus have offered additional support for the rally, but the drumbeat of noise non potential bad blood brewing between the US and China could slow the progress of this rally soon.
  • 10YBTPJun20 – the Italian June, 10-year sovereign bond (BTP) future: the ECB is unlikely to expand its purchase programme today, but we are watching closely for indications of how aggressively it is willing to tilt its PEPP programme purchases in favour of peripheral debt, as the ECB is the critical support for propping up funding of peripheral governments running enormous deficits to deal with the Covid19 crisis.
  • OILUSJUL20 (WTI) and OILUKJUN20: Crude oil is tough to differentiate from the broader recovery across risk assets, as prices rallied a further two dollars, or over 10%, overnight in the wake of yesterday’s almost 10% advance, with some supportive news of a jump in demand and a draw on US weekly gasoline supplies. US output my fall by 2 million barrels per day in May, and Russia said that it would reduce output by about 20%, with Norway joining in announcing its own reductions. Still, concerns for storage filling in the US and globally linger.

What is going on?

Facebook and Gilead news yesterday with online advertising activity stabilizing in April and Gilead study showing positive impact from treating COVID-19 with Remdesivir were the two things that powered equity sentiment in equity futures after the market close.

The FOMC statement for April, released late yesterday, pointed to Fed concerns that the economy won’t snap back immediately, as the ongoing crisis “poses considerable risks to the economic outlook over the medium term”. That medium term language suggests that the Fed is concerned that the recovery will not be v-shaped and will remain in an easy stance for a long period.

US GDP dropped at a -4.7% annualized clip in Q1 – arguably a somewhat remarkably negative number as the widespread shutdowns were only implemented over the first couple of weeks of March and a surge in hoarding demand for supplies would have driven some consumption levels higher.


What we are watching next?

Apple and Amazon earnings are expected to be released after the close tonight with consensus expecting Apple to see revenue down 7% y/y and EPS down 9% y/y with products expected to be weak while their services segment is expected to have performed strongly. Consensus is looking for Amazon to see revenue up 24% y/y in Q1 and EPS up 28% y/y as the e-commerce and cloud computing giant benefitted from work-from-home policies and lockdowns. This is the last chance for bears to get their catalyst on the downside. If earnings from Apple and Amazon are strong sentiment could be bolstered even more.

ECB meeting few are expecting any expansion in the ECB purchase amounts, as the central bank has only purchases a fraction of the EUR 750 billion it plans to purchase in government bonds, though an expansion of that programme (or suggestion that this ceiling could be lifted down the road) may be hinted at in today’s meeting. More interesting is whether the ECB plans to move more aggressively to reduce sovereign bond yield spreads across the EU, a move that quickly gets the ECB into a political hot seat if it goes all in. Such a move could support the euro, and the lack thereof could see further pressure on the single currency.

US weekly jobless claims – as portions of the US open up from shutdowns, this is the high-frequency data point best suited to indicate the pace of the economic recovery after it peaked quickly in the wake of the shutdowns announced back in March. Expectations for today’s figure are 3.5M, which would still represent a level of more than five times worse than the worst single reading in the history of the data series before this crisis started.


Economic Calendar Highlights (times GMT)

  • 0855 – Germany Apr. Unemployment Rate/Change -  the market looking for the largest jump in unemployment – at +75k,  for a single month since the financial crisis of ‘08-09 -
  • 0900 – Euro Zone Q1 GDP estimate – expectations for a -3.8% QoQ reading, which is nearly a -15% annualized clip.
  • 1145 – ECB Meeting with press conference to follow 1230 – watching mostly for all things periphery-related in press conference
  • 1230 – US Weekly Initial Jobless Claims – as noted above, expected to drop again, but need to continue dropping aggressively to suggest any semblance of normalcy returning.


Follow SaxoStrats on the daily Saxo Markets Call on your favorite podcast app:

Apple Sportify Soundcloud Stitcher


Saxo Capital Markets (Australia) Limited prepares and distributes information/research produced within the Saxo Bank Group for informational purposes only. In addition to the disclaimer below, if any general advice is provided, such advice does not take into account your individual objectives, financial situation or needs. You should consider the appropriateness of trading any financial instrument as trading can result in losses that exceed your initial investment. Please refer to our Analysis Disclaimer, and our Financial Services Guide and Product Disclosure Statement. All legal documentation and disclaimers can be found at

The Saxo Bank Group entities each provide execution-only service. Access and use of Saxo News & Research and any Saxo Bank Group website are subject to (i) the Terms of Use; (ii) the full Disclaimer; and (iii) the Risk Warning in addition (where relevant) to the terms governing the use of the website of a member of the Saxo Bank Group.

Saxo News & Research is provided for informational purposes, does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. No Saxo Bank Group entity shall be liable for any losses that you may sustain as a result of any investment decision made in reliance on information on Saxo News & Research.

To the extent that any content is construed as investment research, such content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication.

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments.Saxo Capital Markets does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo Capital Markets or its affiliates.

Please read our disclaimers:
- Full Disclaimer (
- Analysis Disclaimer (
- Notification on Non-Independent Investment Research (

Saxo Capital Markets (Australia) Limited
Suite 1, Level 14, 9 Castlereagh St
Sydney NSW 2000

Contact Saxo

Select region


The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit

Saxo Capital Markets (Australia) Limited ABN 32 110 128 286 AFSL 280372 (‘Saxo’ or ‘Saxo Capital Markets’) is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms, Financial Services Guide, Product Disclosure Statement and Target Market Determination to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Saxo Capital Markets does not provide ‘personal’ financial product advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Capital Markets does not take into account an individual’s needs, objectives or financial situation. The Target Market Determination should assist you in determining whether any of the products or services we offer are likely to be consistent with your objectives, financial situation and needs.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website is not intended for residents of the United States and Japan.

Please click here to view our full disclaimer.